Q97963713
motion by Per Landgren et al. 2000
Press Enter · cited answer in seconds
0 sources
Q97963713
Summary
Q97963713 is an individual motion[1].
Key Facts
- Q97963713 authored Per Landgren[2].
- Q97963713 authored Per Landgren[3].
- Q97963713's instance of is recorded as individual motion[4].
- Q97963713's part of the series is recorded as motions of the 2000–2001 legislative session of the Riksdag[5].
- Q97963713's language of work or name is recorded as Swedish[6].
- Q97963713's publication date is recorded as +2000-10-05T00:00:00Z[7].
- Q97963713's main subject is recorded as medication[8].
- Q97963713's work available at URL is recorded as http://data.riksdagen.se/dokument/GO02So341[9].
- Q97963713's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GO02So341[10].
- Q97963713's applies to jurisdiction is recorded as Sweden[11].
- Q97963713's legal citation of this text is recorded as Mot. 2000/01:So341[12].
- Q97963713's title is recorded as Narkotiska läkemedel[13].
- Q97963713's maintained by WikiProject is recorded as Project Riksdagen's documents[14].
- Q97963713's copyright status is recorded as public domain[15].
- Q97963713's legislative committee is recorded as Committee on Health and Welfare[16].
- Q97963713's Swedish Riksdag document ID is recorded as GO02So341[17].
Body
Works and Contributions
Authored works include Per Landgren[2], a politician[18], b. 1958[19], of Sweden[20].